Präzisionsmedizin – Eine Reise in Die Zukunft Der Diabetologie www.diabeteskongress.de 2021
DOI: 10.1055/s-0041-1727318
|View full text |Cite
|
Sign up to set email alerts
|

Unterschiede bei der HbA1c-Senkung zwischen Insulin glargin 300 E / ml (Gla-300) und Insulin degludec 100 E / ml (IDeg-100) bei Typ-2-Diabetespatienten ≥ 70 Jahre in der BRIGHT-Studie

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles